BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 28703769)

  • 21. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV.
    Sadir R; Imberty A; Baleux F; Lortat-Jacob H
    J Biol Chem; 2004 Oct; 279(42):43854-60. PubMed ID: 15292258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology.
    Mortier A; Gouwy M; Van Damme J; Proost P; Struyf S
    J Leukoc Biol; 2016 Jun; 99(6):955-69. PubMed ID: 26744452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis.
    Ali S; Palmer AC; Fritchley SJ; Maley Y; Kirby JA
    Biochem J; 2001 Sep; 358(Pt 3):737-45. PubMed ID: 11535134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response.
    Iwata S; Yamaguchi N; Munakata Y; Ikushima H; Lee JF; Hosono O; Schlossman SF; Morimoto C
    Int Immunol; 1999 Mar; 11(3):417-26. PubMed ID: 10221653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy.
    Barreira da Silva R; Laird ME; Yatim N; Fiette L; Ingersoll MA; Albert ML
    Nat Immunol; 2015 Aug; 16(8):850-8. PubMed ID: 26075911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration.
    Proost P; Mortier A; Loos T; Vandercappellen J; Gouwy M; Ronsse I; Schutyser E; Put W; Parmentier M; Struyf S; Van Damme J
    Blood; 2007 Jul; 110(1):37-44. PubMed ID: 17363734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor.
    Jenh CH; Cox MA; Hipkin W; Lu T; Pugliese-Sivo C; Gonsiorek W; Chou CC; Narula SK; Zavodny PJ
    Cytokine; 2001 Aug; 15(3):113-21. PubMed ID: 11554781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation.
    Campbell TB; Broxmeyer HE
    Front Biosci; 2008 Jan; 13():1795-805. PubMed ID: 17981668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.
    Proost P; De Meester I; Schols D; Struyf S; Lambeir AM; Wuyts A; Opdenakker G; De Clercq E; Scharpé S; Van Damme J
    J Biol Chem; 1998 Mar; 273(13):7222-7. PubMed ID: 9516414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha.
    Proost P; Struyf S; Schols D; Durinx C; Wuyts A; Lenaerts JP; De Clercq E; De Meester I; Van Damme J
    FEBS Lett; 1998 Jul; 432(1-2):73-6. PubMed ID: 9710254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation.
    Xanthou G; Williams TJ; Pease JE
    Eur J Immunol; 2003 Oct; 33(10):2927-36. PubMed ID: 14515277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
    Xanthou G; Duchesnes CE; Williams TJ; Pease JE
    Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10).
    Campanella GS; Lee EM; Sun J; Luster AD
    J Biol Chem; 2003 May; 278(19):17066-74. PubMed ID: 12571234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of cysteine-X-cysteine motif chemokine ligands 9, 10, and 11, their receptor CXCR3, and their possible role on the recruitment of immune cells at the maternal-conceptus interface in pigs.
    Han J; Gu MJ; Yoo I; Choi Y; Jang H; Kim M; Yun CH; Ka H
    Biol Reprod; 2017 Jul; 97(1):69-80. PubMed ID: 28859287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.
    Ranjbaran H; Wang Y; Manes TD; Yakimov AO; Akhtar S; Kluger MS; Pober JS; Tellides G
    Circulation; 2006 Sep; 114(12):1293-300. PubMed ID: 16940188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
    Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.
    Shioda T; Kato H; Ohnishi Y; Tashiro K; Ikegawa M; Nakayama EE; Hu H; Kato A; Sakai Y; Liu H; Honjo T; Nomoto A; Iwamoto A; Morimoto C; Nagai Y
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6331-6. PubMed ID: 9600965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.
    Beckenkamp A; Willig JB; Santana DB; Nascimento J; Paccez JD; Zerbini LF; Bruno AN; Pilger DA; Wink MR; Buffon A
    PLoS One; 2015; 10(7):e0134305. PubMed ID: 26222679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Post-Translational Modifications of Chemokines by CD26 in Cancer.
    De Zutter A; Van Damme J; Struyf S
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An angiotensin-converting enzyme inhibitor modulates stromal-derived factor-1 through CD26/dipeptidyl peptidase IV to inhibit laser-induced choroidal neovascularization.
    Li H; Wang YS
    Mol Vis; 2013; 19():1107-21. PubMed ID: 23734079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.